SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-386428"
 

Sökning: id:"swepub:oai:DiVA.org:uu-386428" > A Genome-Wide Assoc...

  • Kharazmi, MohammadUppsala universitet,Ortopedi,Uppsala Univ, Sweden (författare)

A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture

  • Artikel/kapitelEngelska2019

Förlag, utgivningsår, omfång ...

  • 2019-04-20
  • SPRINGER,2019
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-386428
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-386428URI
  • https://doi.org/10.1007/s00223-019-00546-9DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-158543URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding Agencies|Swedish Research Council [521-2011-2440, 521-2014-3370, 2015-03527]; Swedish Heart and Lung Foundation [20120557, 20140291, 20170711]; Selanders foundation; Thureus foundation; Swedish Medical Products Agency; Clinical Research Support (ALF) at Uppsala University; Ostergotland County Council [LIO-698411]; Science for Life Laboratory; Uppsala University; Research Council Swedish [2017-00641]; Swedish Research Council
  • Atypical femoral fracture is a well-documented adverse reaction to bisphosphonates. It is strongly related to duration of bisphosphonate use, and the risk declines rapidly after drug withdrawal. The mechanism behind bisphosphonate-associated atypical femoral fracture is unclear, but a genetic predisposition has been suggested. With the aim to identify common genetic variants that could be used for preemptive genetic testing, we performed a genome-wide association study. Cases were recruited mainly through reports of adverse drug reactions sent to the Swedish Medical Products Agency on a nation-wide basis. We compared atypical femoral fracture cases (n=51) with population-based controls (n=4891), and to reduce the possibility of confounding by indication, we also compared with bisphosphonate-treated controls without a current diagnosis of cancer (n=324). The total number of single-nucleotide polymorphisms after imputation was 7,585,874. A genome-wide significance threshold of p<5x10(-8) was used to correct for multiple testing. In addition, we performed candidate gene analyses for a panel of 29 genes previously implicated in atypical femoral fractures (significance threshold of p<5.7x10(-6)). Compared with population controls, bisphosphonate-associated atypical femoral fracture was associated with four isolated, uncommon single-nucleotide polymorphisms. When cases were compared with bisphosphonate-treated controls, no statistically significant genome-wide association remained. We conclude that the detected associations were either false positives or related to the underlying disease, i.e., treatment indication. Furthermore, there was no significant association with single-nucleotide polymorphisms in the 29 candidate genes. In conclusion, this study found no evidence of a common genetic predisposition for bisphosphonate-associated atypical femoral fracture. Further studies of larger sample size to identify possible weakly associated genetic traits, as well as whole exome or whole-genome sequencing studies to identify possible rare genetic variation conferring a risk are warranted.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Michaëlsson, Karl,1959-Uppsala universitet,Ortopedi,Uppsala Univ, Sweden(Swepub:uu)karlmich (författare)
  • Schilcher, JörgLinköpings universitet,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten,Region Östergötland, Ortopedkliniken i Linköping(Swepub:liu)jorsc03 (författare)
  • Eriksson, Niclas,1978-Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Institutionen för medicinska vetenskaper,Uppsala Univ, Sweden(Swepub:uu)nieri103 (författare)
  • Melhus, HåkanUppsala universitet,Klinisk farmakogenomik och osteoporos,Uppsala Univ, Dept Med Sci, Uppsala, Sweden(Swepub:uu)hakamelh (författare)
  • Wadelius, MiaUppsala universitet,Klinisk farmakogenomik och osteoporos,Uppsala Univ, Sweden(Swepub:uu)miawadel (författare)
  • Hallberg, Pär,1974-Uppsala universitet,Klinisk farmakogenomik och osteoporos,Uppsala Univ, Sweden(Swepub:uu)pahal677 (författare)
  • Uppsala universitetOrtopedi (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Calcified Tissue International: SPRINGER105:1, s. 51-670171-967X1432-0827

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy